Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Publication year range
1.
Sci Total Environ ; 927: 172340, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38608909

ABSTRACT

Tackling the impact of missing data in water management is crucial to ensure the reliability of scientific research that informs decision-making processes in public health. The goal of this study is to ascertain the root causes associated with cyanobacteria proliferation under major missing data scenarios. For this purpose, a dynamic missing data management methodology is proposed using Bayesian Machine Learning for accurate surface water quality prediction of a river from Limia basin (Spain). The methodology used entails a sequence of analytical steps, starting with data pre-processing, followed by the selection of a reliable dynamic Bayesian missing value prediction system, leading finally to a supervised analysis of the behavioral patterns exhibited by cyanobacteria. For that, a total of 2,118,844 data points were used, with 205,316 (9.69 %) missing values identified. The machine learning testing showed the iterative structural expectation maximization (SEM) as the best performing algorithm, above the dynamic imputation (DI) and entropy-based dynamic imputation methods (EBDI), enhancing in some cases the accuracy of imputations by approximately 50 % in R2, RMSE, NRMSE, and logarithmic loss values. These findings can impact how data on water quality is being processed and studied, thus, opening the door for more reliable water management strategies that better inform public health decisions.


Subject(s)
Bayes Theorem , Cyanobacteria , Environmental Monitoring , Machine Learning , Water Quality , Cyanobacteria/growth & development , Environmental Monitoring/methods , Spain , Rivers/microbiology , Rivers/chemistry , Water Microbiology
2.
Palliat Med ; 18(3): 177-83, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15198130

ABSTRACT

Breakthrough pain (BKP) is a transitory flare of pain that occurs on a background of relatively well controlled baseline pain. Previous surveys have found that BKP is highly prevalent among patients with cancer pain and predicts more severe pain, pain-related distress and functional impairment, and relatively poor quality of life. An international group of investigators assembled by a task force of the International Association for the Study of Pain (IASP) evaluated the prevalence and characteristics of BKP as part of a prospective, cross-sectional survey of cancer pain. Fifty-eight clinicians in 24 countries evaluated a total of 1095 patients with cancer pain using patient-rated items from the Brief Pain Inventory (BPI) and observer-rated measures. The observer-rated information included demographic and tumor-related data, the occurrence of BKP, and responses on checklists of pain syndromes and pathophysiologies. The clinicians reported BKP in 64.8% of patients. Physicians from English-speaking countries were significantly more likely to report BKP than other physicians. BKP was associated with higher pain scores and functional interference on the BPI. Multivariate analysis showed an independent association of BKP with the presence of more than one pain, a vertebral pain syndrome, pain due to plexopathy, and English-speaking country. These data confirm the high prevalence of BKP, its association with more severe pain and functional impairment, and its relationship to specific cancer pain syndromes. Further studies are needed to characterize subtypes of BKP. The uneven distribution of BKP reporting across pain specialists from different countries suggests that more standardized methods for diagnosing BKP are needed.


Subject(s)
Neoplasms , Pain/prevention & control , Analysis of Variance , Female , Humans , Male , Middle Aged , Pain/classification , Pain/epidemiology , Pain Measurement , Prevalence , Syndrome
3.
Ontogenez ; 28(2): 117-20, 1997.
Article in Russian | MEDLINE | ID: mdl-9173349

ABSTRACT

Using radioimmunologic assay, we have studied the content of prolactin in the pituitary and its release into general circulation in 18-, 20-, and 22-day-old rat fetuses under normal conditions and after pharmacological block of dopamine receptors. Prolactin was found in the pituitaries of the fetuses from day 5 and in blood serum, from day 18; its levels were progressively increasing up to the end of prenatal development. Administration of haloperidol, an inhibitor of dopamine D2 receptors, to pregnant female increased the level of prolactin in fetus plasma from day 20 and diminished its content in the pituitary gland from day 22. These data provide evidence for secretion of prolactin by the pituitary and sensitivity of lactotrophs to dopamine during prenatal development.


Subject(s)
Dopamine/physiology , Pituitary Gland, Anterior/embryology , Pituitary Gland, Anterior/metabolism , Prolactin/metabolism , Animals , Dopamine Antagonists/pharmacology , Female , Fetal Blood/chemistry , Gestational Age , Haloperidol/pharmacology , Male , Pituitary Gland, Anterior/chemistry , Pituitary Gland, Anterior/cytology , Pituitary Gland, Anterior/drug effects , Pregnancy , Prolactin/analysis , Prolactin/drug effects , Radioimmunoassay , Rats , Rats, Wistar , Receptors, Dopamine/drug effects , Receptors, Dopamine/physiology
4.
Ontogenez ; 28(2): 121-4, 1997.
Article in Russian | MEDLINE | ID: mdl-9173350

ABSTRACT

Using the technique of radioimmunoassay, we studied the secretion of prolactin and its control by dopaminergic system in 22-day-old rat fetuses under normal conditions and after pharmacological inhibition of dopamine receptors. In order to elucidate the origin of prolactin and dopamine participating in this process, we used decapitation and encephalectomy of fetuses in utero. Decapitation of fetuses did not result in any changes of baseline prolactin secretion into blood in males and insignificantly decreased it in females as compared with nonoperated controls. We conclude that prolactin detected in blood plasma of nonoperated fetuses does not originate in the pituitary, and any prolactin synthesized in the pituitary is not secreted into blood. Inhibition of dopamine receptors in decapitated fetuses did not result in any changes of prolactin level in blood. This provided evidence that in nonoperated fetuses, it is pituitary prolactin which is secreted in response to haloperidol, while the secretion of nonpituitary prolactin is not controlled by dopamine. Encephalectomy increased prolactin level in plasma and resulted in a drastic decrease of its level in the pituitary. The block of dopamine receptors did not affect the level of prolactin in blood plasma or pituitary of encephalectomized fetuses. We conclude that the inhibitory dopaminergic control of prolactin secretion by the pituitary during the prenatal period is accomplished just as in adult animals by dopaminergic neurons of hypothalamus.


Subject(s)
Dopamine/physiology , Pituitary Gland, Anterior/embryology , Pituitary Gland, Anterior/metabolism , Prolactin/antagonists & inhibitors , Prolactin/metabolism , Animals , Brain/surgery , Dopamine Antagonists/pharmacology , Female , Gestational Age , Haloperidol/pharmacology , Hypothalamus/drug effects , Hypothalamus/embryology , Hypothalamus/physiology , Male , Pituitary Gland, Anterior/cytology , Pituitary Gland, Anterior/drug effects , Pregnancy , Prolactin/analysis , Prolactin/drug effects , Radioimmunoassay , Rats , Rats, Wistar , Receptors, Dopamine/drug effects , Receptors, Dopamine/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...